Nippon India Pharma Fund Direct-Growth
NAV
₹573.5263
as on 17 Oct 2025, 11:13 PM
₹1.1266(0.20%)
Last Change
Scheme Information
Nippon India Pharma Fund Direct-Growth
as of 30 Sep 2025, 05:30 AM
₹8,113.59 Cr
0.89%
0.56%
Open-End
Growth
Exit load of 1% if redeemed within 1 month.
BSE Healthcare Total Return Index
View
Sectors Holding in this Mutual Fund
Healthcare
99.44%
₹8,068.16 Cr
Others
0.56%
₹45.44 Cr
Healthcare
99.44%
₹8,068.16 Cr
Others
0.56%
₹45.44 Cr
Sun Pharmaceutical Industries Ltd.
12.57%
₹1,019.88 Cr
Divi's Laboratories Ltd.
9.49%
₹769.98 Cr
Lupin Ltd.
5.82%
₹472.21 Cr
Cipla Ltd.
5.62%
₹455.98 Cr
Dr. Reddy's Laboratories Ltd.
5.49%
₹445.44 Cr
Others
61.01%
₹4,950.10 Cr
Sun Pharmaceutical Industries Ltd.
12.57%
₹1,019.88 Cr
Divi's Laboratories Ltd.
9.49%
₹769.98 Cr
Lupin Ltd.
5.82%
₹472.21 Cr
Cipla Ltd.
5.62%
₹455.98 Cr
Dr. Reddy's Laboratories Ltd.
5.49%
₹445.44 Cr
Others
61.01%
₹4,950.10 Cr
Funds in this Category
This fund's returns: 23.17%
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth
Min. Investment
₹100
29.12
Category Returns
19.68%
29.12%
3Y Returns
29.12 %
SBI Healthcare Opportunities Fund Direct Plan-Growth
Min. Investment
₹500
27.39
Category Returns
19.68%
29.12%
3Y Returns
27.39 %
UTI Healthcare Fund Direct-Growth
Min. Investment
₹500
26.16
Category Returns
19.68%
29.12%
3Y Returns
26.16 %
About Nippon India Pharma Fund Direct-Growth
Nippon India Pharma Fund Direct-Growth scheme return performance in last 1 year is -0.72%, in last 3 years is 86.96% and 720.91% since scheme launch. The min. SIP amount to invest in this scheme is ₹100.
Scheme Details
AUM: | ₹8,113.59 Cr |
Category: | Equity: Sectoral-Pharma |
Launch Date: | Invalid date |
Fund Type: | Open-End |
AMC Information
Nippon India Mutual Fund
Address
Investment Performance
₹ 1,00,000
would have given a return of
₹1,10,871
₹1,21,647
₹1,82,019
₹1,86,957
Bank Account
Fixed Deposit
Regular Mutual Fund
This Fund on Paytm Money
This Mutual Fund
Profit (absolute return)
₹86,957
86.96%
Investment Returns
Scheme Riskometer
Investors understand that their principal will be at very high risk